C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2004
11/18/2004	US20040229914 Novel crystalline form-VI of donepezil hydrochloride and process for the preparation thereof
11/18/2004	US20040229913 Administering 3.0 mg to 10 mg of 1-benzyl-4-(5,6-dimethoxy-1-indanon)2-yl)methylpiperidine or a pharmaceutically acceptable salt thereof to treat severe Alzheimer's dementia in the patient
11/18/2004	US20040229883 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; therapy of metabolic, feeding, and sexual disorders including obesity
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229860 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis
11/18/2004	US20040229859 Beta-amino acid compounds as integrin antagonists
11/18/2004	US20040229858 VLA-4 inhibitor compounds
11/18/2004	US20040229819 Hemiasterlin derivatives and uses thereof
11/18/2004	US20040228854 Novel chemical substance having morphogenetic and growth-accelerating activities
11/18/2004	CA2526904A1 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004	CA2524894A1 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them
11/18/2004	CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477479A1 Process for the preparation of the D-(-)-tartrate salt of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-YL)-1-propanol
11/17/2004	EP1476427A2 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone
11/17/2004	EP1347960B1 Process for preparing (+) trans-4-p-fluorophenyl-3-hydroxymethyl-1
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1087953B1 Nitrate salts of antihypertensive medicines
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP0942732B1 Use of nk-1 receptor antagonists for treating movement disorders
11/17/2004	EP0942731B1 Use of nk-1 receptor antagonists for treating substance use disorders
11/17/2004	CN1547579A 4-(phenyl-piperdin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/17/2004	CN1547575A Novel phenylalkyl diamine and amide analogs
11/16/2004	US6818773 Synthesis of 4-[(Z)-4-bromophenyl)(ethoxyimino) methyl]-1'-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbony)]-4'-methyl-1,4-′bipiperidine
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818638 Melvinolin derivatives
11/11/2004	WO2004096794A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
11/11/2004	WO2004096771A1 Biaryl compounds having activity at the 5ht5a receptor
11/11/2004	WO2004096770A1 Process for preparing almodipine mesylate monohydrate
11/11/2004	WO2004096769A1 Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives
11/11/2004	WO2004096761A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
11/11/2004	WO2004096287A2 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
11/11/2004	WO2004096286A2 Antiviral phosphonate analogs
11/11/2004	WO2004096236A2 Immunomodulator phosphonate conjugates
11/11/2004	WO2004096235A2 Anti-cancer phosphonate analogs
11/11/2004	US20040225029 Dental composition with improved light stability
11/11/2004	US20040224985 for controlling weight; pyrrolidine or piperidine compounds
11/11/2004	US20040224978 CCR8 inhibitors
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	CA2523585A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
11/11/2004	CA2523083A1 Antiviral phosphonate analogs
11/11/2004	CA2521932A1 Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives
11/11/2004	CA2519840A1 Anti-cancer phosphonate analogs
11/10/2004	EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474392A1 Polymorphic form xvi of fexofenadine hydrochloride
11/10/2004	EP1474391A1 Water soluble phenylglycine derivatives
11/10/2004	EP1473995A1 Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
11/10/2004	EP1159258B1 Amide compounds for the potentiation of cholinergic activity
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545501A Novel cyclohexyl sulphones
11/10/2004	CN1174968C 1, 2 -bis -adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/10/2004	CN1174958C Purification process of keto acid
11/10/2004	CN1174745C Use of coating as taste masking agent for oral preparation
11/09/2004	US6815549 Reacting an acetylinic compound containing halogen or sulfonate group with a 4-((4-hydroxydiphenylmethyl)-1-piperidine) to form anintermediate, condensing it with an dimethylbenzene acetates
11/09/2004	US6815548 Process for preparing a piperidine derivative
11/09/2004	US6815458 Nervous system disorders
11/09/2004	CA2345286C Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor
11/09/2004	CA2144344C Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents
11/04/2004	WO2004094412A1 Nk-2 antagonist basic linear compounds and formulations containing them
11/04/2004	WO2004094382A1 Muscarinic agonists
11/04/2004	WO2004094381A1 Cyclic quaternary amino derivatives as modulators of chemokine receptors
11/04/2004	WO2004094380A1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists
11/04/2004	WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004	WO2004074812A3 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/04/2004	WO2004069794A3 New arylpiperazinyl compounds
11/04/2004	WO2004060865A3 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
11/04/2004	WO2004056774A3 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
11/04/2004	WO2004042351A3 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/04/2004	WO2003087044A3 Novel carboxamide compounds for use in mch receptor related disorders
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220411 Oxalic acid derivatives
11/04/2004	US20040220409 Reacting 4-fluoro-1-bromobenzene (VI) with 2,2,2-trifluoroethanol in the presence of a base and a copper-containing catalyst
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220223 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220192 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
11/04/2004	US20040220191 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
11/04/2004	US20040220174 for example, 1-(4-methoxyphenyl)-7-oxo-6-[5-(2-oxo-1-piperidinyl)2-pyridinyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; use as anticoagulant agent for treatment of thromboembolic disorders
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	CA2526880A1 Cyclic quaternary amino derivatives as modulators of chemokine receptors
11/04/2004	CA2523200A1 Nk-2 antagonist basic linear compounds and formulations containing them
11/04/2004	CA2518839A1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists
11/04/2004	CA2518324A1 Muscarinic agonists
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472223A1 Gamma secretase inhibitors
11/03/2004	EP1472222A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
11/03/2004	EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004	EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004	EP1140832A4 Process for preparing arylpiperidine carbinol intermediates and derivatives
11/03/2004	EP1083899A4 Method of enhancing lysosomal alpha-galactosidase a
11/03/2004	EP0993446B1 Process for preparing nifedipine
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides

1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 380